BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 33332531)

  • 21. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
    Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
    Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma progression by suppressing STAT3 phosphorylation.
    Ding H; Liu J; Zou R; Cheng P; Su Y
    J Exp Clin Cancer Res; 2019 May; 38(1):189. PubMed ID: 31072375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histone methyltransferase SETDB1 promotes cells proliferation and migration by interacting withTiam1 in hepatocellular carcinoma.
    Zhang Y; Huang J; Li Q; Chen K; Liang Y; Zhan Z; Ye F; Ni W; Chen L; Ding Y
    BMC Cancer; 2018 May; 18(1):539. PubMed ID: 29739365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma.
    Fu SJ; Shen SL; Li SQ; Hua YP; Hu WJ; Guo B; Peng BG
    BMC Cancer; 2018 Aug; 18(1):815. PubMed ID: 30103712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathways.
    Meng F; Zhang S; Song R; Liu Y; Wang J; Liang Y; Wang J; Han J; Song X; Lu Z; Yang G; Pan S; Li X; Liu Y; Zhou F; Wang Y; Cui Y; Zhang B; Ma K; Zhang C; Sun Y; Xin M; Liu L
    EBioMedicine; 2019 Jun; 44():237-249. PubMed ID: 31176678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma.
    Huang B; Huang M; Li Q
    Pathol Res Pract; 2018 Dec; 214(12):1980-1986. PubMed ID: 30274685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma.
    Zhou Q; Zhang W; Wang Z; Liu S
    BMC Cancer; 2019 Jul; 19(1):731. PubMed ID: 31340767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HOX Antisense lincRNA HOXA-AS2 Promotes Tumorigenesis of Hepatocellular Carcinoma.
    Wang F; Yang H; Deng Z; Su Y; Fang Q; Yin Z
    Cell Physiol Biochem; 2016; 40(1-2):287-296. PubMed ID: 27855366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-SMC condensin I complex subunit H enhances proliferation, migration, and invasion of hepatocellular carcinoma.
    Sun C; Huang S; Wang H; Xie R; Zhang L; Zhou Q; He X; Ju W
    Mol Carcinog; 2019 Dec; 58(12):2266-2275. PubMed ID: 31523845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non‑coding RNA ST8SIA6‑AS1 promotes the migration and invasion of hypoxia‑treated hepatocellular carcinoma cells through the miR‑338/MEPCE axis.
    Zhang B; Liu Z; Liu J; Cao K; Shan W; Wen Q; Wang R
    Oncol Rep; 2021 Jan; 45(1):73-82. PubMed ID: 33416148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-26b suppresses hepatocellular carcinoma development by negatively regulating ZNRD1 and Wnt/β-catenin signaling.
    Hu X; Wang R; Ren Z; Liu X; Gu J; Cui G; Li Q
    Cancer Med; 2019 Dec; 8(17):7359-7371. PubMed ID: 31637871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The RNA-binding protein SORBS2 suppresses hepatocellular carcinoma tumourigenesis and metastasis by stabilizing RORA mRNA.
    Han L; Huang C; Zhang S
    Liver Int; 2019 Nov; 39(11):2190-2203. PubMed ID: 31365778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression.
    Yan S; Tang Z; Chen K; Liu Y; Yu G; Chen Q; Dang H; Chen F; Ling J; Zhu L; Huang A; Tang H
    J Exp Clin Cancer Res; 2018 Sep; 37(1):214. PubMed ID: 30176933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA TUG1 interacting with miR-144 contributes to proliferation, migration and tumorigenesis through activating the JAK2/STAT3 pathway in hepatocellular carcinoma.
    Lv J; Kong Y; Gao Z; Liu Y; Zhu P; Yu Z
    Int J Biochem Cell Biol; 2018 Aug; 101():19-28. PubMed ID: 29791864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models.
    Andreozzi M; Quintavalle C; Benz D; Quagliata L; Matter M; Calabrese D; Tosti N; Ruiz C; Trapani F; Tornillo L; Fusco A; Heim MH; Ng CK; Pallante P; Terracciano LM; Piscuoglio S
    Neoplasia; 2016 Dec; 18(12):724-731. PubMed ID: 27855356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-552 promotes the proliferation, migration and EMT of hepatocellular carcinoma cells by inhibiting AJAP1 expression.
    Qu W; Wen X; Su K; Gou W
    J Cell Mol Med; 2019 Feb; 23(2):1541-1552. PubMed ID: 30597727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel circular RNA circ-LRIG3 facilitates the malignant progression of hepatocellular carcinoma by modulating the EZH2/STAT3 signaling.
    Sun S; Gao J; Zhou S; Li Y; Wang Y; Jin L; Li J; Liu B; Zhang B; Han S; Ding H; Li X
    J Exp Clin Cancer Res; 2020 Nov; 39(1):252. PubMed ID: 33222697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
    Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
    Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LINC01433 promotes hepatocellular carcinoma progression via modulating the miR-1301/STAT3 axis.
    Huang H; Bu YZ; Zhang XY; Liu J; Zhu LY; Fang Y
    J Cell Physiol; 2019 May; 234(5):6116-6124. PubMed ID: 30317567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An alternative POLDIP3 transcript promotes hepatocellular carcinoma progression.
    Liu XN; Yuan JH; Wang TT; Pan W; Sun SH
    Biomed Pharmacother; 2017 May; 89():276-283. PubMed ID: 28236701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.